Synergetics USA, Inc. engages in the design, manufacture, and marketing of precision-engineered, microsurgical instruments, and capital equipment and devices primarily for use in vitreoretinal surgery and neurosurgical applications worldwide. Its products are designed to support micro or minimally invasive surgical procedures. The company designs and manufactures disposable and nondisposable supplies and accessories for use with its products. It also develops various microsurgical instruments, including scissors, retractors, cannulas, forceps, and other reusable and disposable surgical instruments for ophthalmic and vitreoretinal surgical market. The company’s neurosurgical product line includes Omni ultrasonic aspirator used for tumor removal, bone removal, and resection; and precision neurosurgical instruments. It offers a lesion generator, which is used for minimally invasive pain treatment. In addition, the company manufactures and sells bipolar electrosurgical generators and other generators based on its DualWave technology, as well as complementary instrumentation and disposable products for use in neurosurgery, spine surgery, pain control, and dental applications. Its Bident Bipolar Tissue Management System allows dentists to work in direct contact with metal implants, nerves, bone, and blood vessels, eliminating collateral tissue damage from current spread and heat buildup. Synergetics sells its products to hospitals, clinics, and surgeons through distributors and independent sales representatives. The company was founded in 1991 and is headquartered in O’Fallon, Missouri.